Morningstar

Xebra Brands Ltd Ordinary Shares XBRAF

Stock OTCM

$0.00 0.00 (0.00%)

View Full Chart

As of Jul 23, 2026, 2:36:15 PM Delayed Price Closed

Trading Information

Previous Close Price: $0.00
Day Range: $0.00–0.00
52-Week Range: $0.00–0.05
Bid/Ask: $0.01 / $0.04
Shares Outstanding: 84.14M
Market Cap: $8,414.49
Volume/Avg: 1,100 / 7,561

Key Statistics

Price/Earnings (Normalized): —
Price/Sales: —
Dividend Yield (Trailing): 0.00%
Dividend Yield (Forward): 0.00%
Total Yield: —

Company Profile

Xebra Brands Ltd is engaged in the processing, manufacturing, design and delivery of cannabis products in areas ranging from wellness to leisure.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Stock Style Box: Small Value
Total Number of Employees: —
Website: https://www.xebrabrands.com

Valuation

Metric	XBRAF
Price/Earnings (Normalized)	—
Price/Book Value	—
Price/Sales	—
Price/Cash Flow	—

Price/Earnings

No chart available

Financial Strength

Metric	XBRAF
Quick Ratio	0.45
Current Ratio	0.46
Interest Coverage	—

Quick Ratio

XBRAF

Profitability

Metric	XBRAF
Return on Assets (Normalized)	−207.59%
Return on Equity (Normalized)	—
Return on Invested Capital (Normalized)	—

Return on Assets

XBRAF

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor

1-Day Chart	Name	Price	Morningstar Rating for Stocks	Capital Allocation	Economic Moat	Market Cap
	Merck KGaA ADR MKKGY			LOCK\|VTm$K!<	LOCK\|#&%pR	$72B
	Haleon PLC ADR HLN			LOCK\|v#GJKM	LOCK\|^gv	$44B
	Teva Pharmaceutical Industries Ltd ADR TEVA			LOCK\|Tb?Xrgt#	LOCK\|lGMQ>	$41B
	Zoetis Inc Class A ZTS			LOCK\|SR?c!w@p	LOCK\|^#	$30B
	Viatris Inc VTRS			LOCK\|^<?%SX	LOCK\|%#D	$19B
	Elanco Animal Health Inc ELAN			LOCK\|q?	LOCK\|xh	$11B
	Dr Reddy's Laboratories Ltd ADR RDY			LOCK\|rghfz^	LOCK\|tm	$10B
	Hims & Hers Health Inc Ordinary Shares - Class A HIMS			LOCK\|mmH&%@p	LOCK\|R<Q	$7B
	Prestige Consumer Healthcare Inc PBH			LOCK\|sbTSQzd	LOCK\|RH>y>	$3B
	Perrigo Co PLC PRGO			LOCK\|^?$!s$	LOCK\|C@	$2B

Sponsor Center

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.